טוען...
Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
PURPOSE: Sorafenib is an effective systemic agent for advanced hepatocellular carcinoma. To increase its efficacy, we evaluated the feasibility and benefit of sorafenib combined with radiotherapy. MATERIALS AND METHODS: From July 2007 to July 2011, 31 patients were treated with a daily dose of 800 m...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Yonsei University College of Medicine
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3743177/ https://ncbi.nlm.nih.gov/pubmed/23918567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2013.54.5.1178 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|